Taurine Lowers Blood Pressure in the Spontaneously Hypertensive Rat by A Catecholamine Independent Mechanism

American Journal of Hypertension

Volumn 2, Issue 12, 1989, Pages 902-912

  Rujikarn, N ^c   Sturman, J A ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Catecholamine; Spontaneously hypertensive rat; Taurine

Indexed keywords

CATECHOLAMINE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; HYPERTENSION; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMAL; BIOMECHANICS; BLOOD PRESSURE; CATECHOLAMINES; HEART; KIDNEY; NOREPINEPHRINE; ORGAN WEIGHT; RATS; RATS, INBRED SHR; RATS, INBRED STRAINS; TAURINE;

EID: 0024814773     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/2.12.909     Document Type: Article

References (17)

1. Jacobsen JG, Smith LH, Jr: Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 1968; 48: 424-511.
2. Chesney RW: New functions for an old molecule. Pediatr Res 1987; 22: 755-759.
3. Nara Y, Yamori Y, Lovenberg W: Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol 1978; 27: 2689-2692.
4. Fujita T, Sato Y: Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats. Amer J Physiol 1986; 250: R1014-R1020.
5. Fujita T, Sato Y, Ando K: Changes in cardiac and hypothalamic noradrenergic activity with taurine in DOCAsalt rats. Amer J Physiol 1986; 251: H926-H933.
6. Fujita T, Ando K, Noda H, et al: Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 1987; 75: 525-532.
7. Rao PS, Rujikarn N, Luber J: A specific sensitive HPLC method for determination of plasma catecholamines. J Chromatography (in press).
8. Gradin K, Dahlof C, Persson B: A low dietary sodium intake reduces noradrenaline release and the blood pressure in spontaneously hypertensive rats. Arch Pharmacol 1986; 322: 364-369.
9. Luft FC, Rankin J, Henry DP, et al: Plasma and urinary norepinephrine values at extremes of sodium intake in normal man. Hypertension 1979; 1: 261-266.
10. Williams GH, Braley LM, Menachery A: Decreased adrenal responsiveness to angiotensin II: a defect present in spontaneously hypertensive rats. J Clin Invest 1982; 69: 31-37.
11. Xie CW, Song DL, Ding JF, et al: Atriopeptin and spontaneous hypertension in rats. Life Sciences 1986, 38: 1035-1039.
12. Van Gelder NM: A central mechanism of action for taurine: osmoregulation, bivalent cations and excitation threshold. Neurochem Res 1983; 8: 687-699.
13. Blaustein MP: Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Amer J Physiol 1977; 232: C165-C173.
14. Robertson JIS: Salt, volume and hypertension: cause or correlation? Kidney Int 1987; 32: 590- 602.
15. Ray L, Chiou XC, Owens R, Wrigley B: Therapeutic implications of hypertension-induced glomerular injury: comparison of Enalapril and a combination of hydralazine, reserpine and hydrochlorothiazide in an experimental model. Amer J Med 1985; 79: 375-415.
16. Feld LG, Van Liew JB, Brentjens JR, Boylan JW: Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment. Kidney Int. 1981; 20: 606-613.
17. Jones MR: Free amino acid pools in the spontaneously hypertensive rat: A longitudinal study. J Nutrition 1988; 118: 579-587.